Literature DB >> 3011218

Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period.

R M Sapolsky, M J Meaney.   

Abstract

During the first two weeks of life rat pups show a markedly reduced adrenocortical response to stress, and this period of adrenocortical quiescence has been termed the 'stress non-responsive period' (SNRP). The adaptive value of the SNRP can be understood in terms of the effects of glucocorticoids on CNS development: excessively high or low corticoid levels are associated with abnormal neural and behavioral development. We have attempted to explain adrenocortical activity during this period in terms of the unique pattern of glucocorticoid-receptor concentrations that exist in the brain and pituitary of the neonatal rat. This pattern of receptor concentrations results in a negative-feedback condition at the level of the brain and pituitary that ensures the low, stable corticoid levels that appear to be optimal for neuronal development in glucocorticoid-sensitive brain regions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011218     DOI: 10.1016/s0006-8993(86)80190-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  207 in total

Review 1.  Neurogenesis in adult mammals: some progress and problems.

Authors:  Elizabeth Gould; Charles G Gross
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 2.  Effects of social isolation on glucocorticoid regulation in social mammals.

Authors:  Louise C Hawkley; Steve W Cole; John P Capitanio; Greg J Norman; John T Cacioppo
Journal:  Horm Behav       Date:  2012-06-01       Impact factor: 3.587

3.  Maternal separation with early weaning: a novel mouse model of early life neglect.

Authors:  Elizabeth D George; Kelly A Bordner; Hani M Elwafi; Arthur A Simen
Journal:  BMC Neurosci       Date:  2010-09-29       Impact factor: 3.288

4.  Effects of developmental stress and lead (Pb) on corticosterone after chronic and acute stress, brain monoamines, and blood Pb levels in rats.

Authors:  Devon L Graham; Curtis E Grace; Amanda A Braun; Tori L Schaefer; Matthew R Skelton; Peter H Tang; Charles V Vorhees; Michael T Williams
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

5.  (+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats.

Authors:  Curtis E Grace; Tori L Schaefer; Nicole R Herring; Matthew R Skelton; Anne E McCrea; Charles V Vorhees; Michael T Williams
Journal:  Synapse       Date:  2008-02       Impact factor: 2.562

6.  Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment.

Authors:  Tori L Schaefer; Matthew R Skelton; Nicole R Herring; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

7.  Age-dependent effects of neonatal methamphetamine exposure on spatial learning.

Authors:  Charles V Vorhees; Matthew R Skelton; Michael T Williams
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

Review 8.  Plasticity of defensive behavior and fear in early development.

Authors:  Christoph P Wiedenmayer
Journal:  Neurosci Biobehav Rev       Date:  2008-11-27       Impact factor: 8.989

Review 9.  Mother to infant or infant to mother? Reciprocal regulation of responsiveness to stress in rodents and the implications for humans.

Authors:  Claire-Dominique Walker; Sophie Deschamps; Karine Proulx; Mai Tu; Camilla Salzman; Barbara Woodside; Sonia Lupien; Nicole Gallo-Payet; Denis Richard
Journal:  J Psychiatry Neurosci       Date:  2004-09       Impact factor: 6.186

Review 10.  Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival.

Authors:  Gad M Gilad; Varda H Gilad
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.